Monoclonal antibodies against mouse SLAM (BIDMC 1296)

Category:    Research Reagents

KeyWords:  Antibody;  Inflammation;  

BIDMC ID:    1296

Abstract:

Signaling lymphocyte activation molecule (SLAM), a glycoprotein expressed on activated lymphocytes and antigen presenting cells, has been shown to be a coregulator of antigen-driven T-cell responses and is one of the two receptors for measles virus. Effective in flow cytometric applications.

Inventor:   Cox Terhorst, Ph.D.

Commercial Opportunity:

Competitive Advantages:

Related Publications:

Howie D. et al 2002. The role of SAP in murine CD150 (SLAM)-mediated T-cell proliferation and interferon gamma production. Blood. 100(8): 2899-907

State of Development:

Related Technology URL:

http://research.bidmc.harvard.edu/research/ResearchPIInfo.ASP?Submit=Display&PersonID=691

Patent Status:

not filed

TVO Contact Info:
     Jodi E Hecht
     Licensing Associate
     jehecht@bidmc.harvard.edu
     Phone: 617-667-4197   Fax: 617-667-0646

     Beth Israel Deaconess Medical Center
     Technology Ventures Office  Room: BR-0200
     330 Brookline Avenue
     Boston, MA 02215